16.16 USD
▲-0.52+6.49%
盘后 15.15 -0.10%
2026-08-03
市值
$480.84M
市盈率
6.23
EPS
2.60
股息率
—
52 周区间
1.57 – 23.57
成交量
728.09K
Beta
-0.27
目标价
38.75
52W 低 1.5752W 高 23.57
价格走势
公司简介
Q32 Bio Inc., a clinical-stage biotechnology company, develops novel biologics to restore healthy immune balance in patients with alopecia areata and other autoimmune and inflammatory diseases driven by pathological immune dysfunction. The company is developing Bempikibart (ADX-914), a fully human anti–interleukin-7 receptor alpha antagonist monoclonal antibody which completed Phase 2a clinical trials, designed to re-regulate adaptive immune function by blocking signaling mediated by interleukin-7 and thymic stromal lymphopoietin for the treatm...